Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 14 August 2014 | By Alexander Gaffney, RAC,
The International Medical Device Regulators Forum (IMDRF) has released two final documents that, once implemented, should make it much easier to get medical device products approved in multiple regions, including the US, EU and Canada.
IMDRF launched in 2012 as the regulators-only successor to the Global Harmonization Task Force (GHTF), which disbanded in December 2012 after its device regulatory members decided to split off and form their own juncture without the involvement of industry.
At present, organizations involved in the IMDRF include the US Food and Drug Administration (FDA), Australia's Therapeutic Goods Administration (TGA), Brazil's National Health Surveillance Agency (ANVISA), Health Canada, the European Union (EU), Japan's Pharmaceuticals and Medical Devices Agency (PMDA), and the Asian Harmonization Working Party (AHWP).
The group has been hard at work, endeavoring to pick up where GHTF left off and increase the pace at which regulatory harmonization occurs.
Among the documents the group has released since its launch: standardized definitions of standalone software, training requirements for auditing organizations, standards for auditing organizations, unique device identification standards, and a regulated products submission (RPS) table of contents (ToC).
The RPS is intended to be a sort of Common Technical Document—created by the International Conference on Harmonisation (ICH), a drug harmonization body, to facilitate the submission of new drugs across multiple regulatory regions—for medical devices.
The effort should, in theory, make it much easier to submit medical device applications to multiple regulatory authorities without needing to fill out region-specific application forms.
In April 2013, IMDRF released the draft version of two RPS ToC files intended to facilitate the submission of IVD and non-IVD products.
The agency has now finalized those two documents: In Vitro Diagnostic Medical Device Market Authorization Table of Contentsand Non-In Vitro Diagnostic Device Market Authorization Table of Contents.
The highly technical documents outline what each participating regulator expects in an application while providing a standard "heading" format for their submission.
For the US medical device industry, it's perhaps worth noting that both documents bear the signature of Jeffery Shuren, director of FDA's Center for Devices and Radiological Health (CDRH). Shuren also currently serves as chair of the IMDRF. His signature is a likely sign that the agency plans to implement the new RPS standards, though it remains unclear as to when that might occur.
IMDRF Document Page
Tags: RPS, Regulated Product Submission, Harmonization, Table of Contents, RPS ToC
Regulatory Focus newsletters
All the biggest regulatory news and happenings.